NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/23/2023
Back to search
Official data from USPTO
COEPTIS THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
COEPTIS THERAPEUTICS
ST13
US500000097249986Class
42
Filing
97249986
Registration
7059072
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
05/23/2023
Trademark type
Word
Nice classes
42
Filing date
02/02/2022
Registration date
05/23/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/23/2023
Last transaction
05/23/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/15/2017
First use in commerce
08/15/2017
Drawing code
4
Owner type
03
Owner location
wexford, PA, US
Examiner
BLAKESLEE,RICHARD A
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Coeptis Therapeutics, Inc
Representatives
Rosenberg, Michelle Patent GC LLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development in the pharmaceuticalbiotechnology and biopharmaceutical fields
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/23/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/07/2023
PUBO
PUBLISHED FOR OPPOSITION
03/07/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/30/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/29/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/29/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/29/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/16/2022
GNRT
NON-FINAL ACTION E-MAILED
11/16/2022
CNRT
NON-FINAL ACTION WRITTEN
11/16/2022
DOCK
ASSIGNED TO EXAMINER
11/15/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/08/2022
NWAP
NEW APPLICATION ENTERED
02/05/2022
Continuous trademark protection
Get notified about every new filing that threatens COEPTIS THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.